Wednesday, 7 October 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Emmessar Biotech & Nutrition Ltd

NSE: EMMESSA · BSE: 524768 · Healthcare · 8 announcements

Share price: ₹23.53
Market cap: ₹11.76 Cr
Revenue (annual): ₹0.37 Cr
Net profit (annual): ₹0.44 Cr
P/E (TTM): 29.7×Sector 53.1×
Promoter holding: 59.53%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Board Meeting Date 2 Other Announcement 1 Debt & Borrowing 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

7 Aug 2026 14:02 IST BSE

Financial Results

Emmessar Biotech & Nutrition Q1 FY27 Results: Net Profit ₹0.1 Cr, Down 50.0% YoY

Emmessar Biotech & Nutrition Ltd reported revenue from operations of ₹0.1 Cr (+0.0% YoY) and net profit of ₹0.1 Cr (-50.0% YoY) for Q1 FY27.

Key figure: Net profit ₹0.1 Cr · -50.0% YoY

Open full results → Read the filing ↗

12 May 2026 14:18 IST BSE

Financial Results

Emmessar Biotech & Nutrition Q4 FY26 Results: Net Profit ₹0 Cr

Emmessar Biotech & Nutrition Ltd reported revenue from operations of ₹0.1 Cr (+0.0% YoY) and net profit of ₹0 Cr for Q4 FY26.

Key figure: Net profit ₹0 Cr

Open full results → Read the filing ↗

12 May 2026 14:17 IST BSE

Financial Results

Emmessar Biotech & Nutrition Financial Results

Emmessar Biotech & Nutrition reported a total income of ₹2.41 Crore for FY26. Net profit stood at ₹0.44 Crore, reflecting stable annual performance for investors.

Value: ₹2.41 Cr

Read the filing ↗